Medpace Holdings, Inc. Income Tax Expense
Medpace Holdings, Inc. (MEDP) reported Income Tax Expense of $30.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-07-23
- Medpace Holdings, Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $30.30M, a 11.60% decline year-over-year.
- Medpace Holdings, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $23.72M, a 563.52% increase year-over-year.
- Medpace Holdings, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was $21.70M, a 28.68% increase year-over-year.
- Medpace Holdings, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $31.70M, a 41.84% increase year-over-year.
- Medpace Holdings, Inc. income tax expense (benefit) for fiscal 2025 was $91.25M, a 27.56% increase from fiscal 2024.
- Medpace Holdings, Inc. income tax expense (benefit) for fiscal 2024 was $71.54M, a 35.30% increase from fiscal 2023.
- Medpace Holdings, Inc. income tax expense (benefit) for fiscal 2023 was $52.87M, a 41.02% increase from fiscal 2022.
- Medpace Holdings, Inc. income tax expense (benefit) for fiscal 2022 was $37.49M, a 87.42% increase from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $30.30M 10-Q · filed 2026-07-23 | $54.02M 10-Q · filed 2026-07-23 | $75.72M derived: sum of 3 quarters · filed 2026-07-23 | $107.42M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $23.72M 10-Q · filed 2026-04-23 | $45.42M derived: sum of 2 quarters · filed 2026-04-23 | $77.12M derived: sum of 3 quarters · filed 2026-04-23 | $111.40M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $21.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $53.40M derived: sum of 2 quarters · filed 2026-02-10 | $87.68M derived: sum of 3 quarters · filed 2026-07-23 | $91.25M 10-K · filed 2026-02-10 |
| 2025-09-30 | $31.70M 10-Q · filed 2025-10-23 | $65.98M derived: sum of 2 quarters · filed 2026-07-23 | $69.55M 10-Q · filed 2025-10-23 | $86.42M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $34.28M 10-Q · filed 2026-07-23 | $37.85M 10-Q · filed 2026-07-23 | $54.72M derived: sum of 3 quarters · filed 2026-07-23 | $77.07M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $3.58M 10-Q · filed 2026-04-23 | $20.44M derived: sum of 2 quarters · filed 2026-04-23 | $42.79M derived: sum of 3 quarters · filed 2026-04-23 | $64.92M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $16.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $39.21M derived: sum of 2 quarters · filed 2026-02-10 | $61.34M derived: sum of 3 quarters · filed 2026-02-10 | $71.54M 10-K · filed 2026-02-10 |
| 2024-09-30 | $22.35M 10-Q · filed 2025-10-23 | $44.48M derived: sum of 2 quarters · filed 2025-10-23 | $54.67M 10-Q · filed 2025-10-23 | $67.08M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $22.13M 10-Q · filed 2025-07-22 | $32.32M 10-Q · filed 2025-07-22 | $44.73M derived: sum of 3 quarters · filed 2026-02-10 | $57.38M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $10.19M 10-Q · filed 2025-04-22 | $22.60M derived: sum of 2 quarters · filed 2026-02-10 | $35.25M derived: sum of 3 quarters · filed 2026-02-10 | $49.93M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $12.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $25.06M derived: sum of 2 quarters · filed 2026-02-10 | $39.74M derived: sum of 3 quarters · filed 2026-02-10 | $52.87M 10-K · filed 2026-02-10 |
| 2023-09-30 | $12.65M 10-Q · filed 2024-10-22 | $27.33M derived: sum of 2 quarters · filed 2024-10-22 | $40.46M 10-Q · filed 2024-10-22 | $45.44M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | $14.68M 10-Q · filed 2024-07-23 | $27.81M 10-Q · filed 2024-07-23 | $32.79M derived: sum of 3 quarters · filed 2025-02-11 | $48.65M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $13.14M 10-Q · filed 2024-04-23 | $18.11M derived: sum of 2 quarters · filed 2025-02-11 | $33.98M derived: sum of 3 quarters · filed 2025-02-11 | $46.62M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | $4.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $20.84M derived: sum of 2 quarters · filed 2025-02-11 | $33.48M derived: sum of 3 quarters · filed 2025-02-11 | $37.49M 10-K · filed 2025-02-11 |
| 2022-09-30 | $15.87M 10-Q · filed 2023-10-24 | $28.50M derived: sum of 2 quarters · filed 2023-10-24 | $32.52M 10-Q · filed 2023-10-24 | $38.40M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $12.64M 10-Q · filed 2023-07-25 | $16.65M 10-Q · filed 2023-07-25 | $22.54M derived: sum of 3 quarters · filed 2024-02-13 | $28.70M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $4.01M 10-Q · filed 2023-04-25 | $9.90M derived: sum of 2 quarters · filed 2024-02-13 | $16.06M derived: sum of 3 quarters · filed 2024-02-13 | $18.81M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $5.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $12.05M derived: sum of 2 quarters · filed 2024-02-13 | $14.80M derived: sum of 3 quarters · filed 2024-02-13 | $20.00M 10-K · filed 2024-02-13 |
| 2021-09-30 | $6.16M 10-Q · filed 2022-10-25 | $8.91M derived: sum of 2 quarters · filed 2022-10-25 | $14.12M 10-Q · filed 2022-10-25 | $17.95M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $2.75M 10-Q · filed 2022-07-26 | $7.96M 10-Q · filed 2022-07-26 | $11.79M derived: sum of 3 quarters · filed 2023-02-14 | $17.32M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $5.20M 10-Q · filed 2022-04-26 | $9.04M derived: sum of 2 quarters · filed 2023-02-14 | $14.57M derived: sum of 3 quarters · filed 2023-02-14 | $20.83M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $9.37M derived: sum of 2 quarters · filed 2023-02-14 | $15.62M derived: sum of 3 quarters · filed 2023-02-14 | $23.15M 10-K · filed 2023-02-14 |
| 2020-09-30 | $5.53M 10-Q · filed 2021-10-26 | $11.79M derived: sum of 2 quarters · filed 2021-10-26 | $19.31M 10-Q · filed 2021-10-26 | $25.72M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $6.26M 10-Q · filed 2021-07-27 | $13.78M 10-Q · filed 2021-07-27 | $20.19M derived: sum of 3 quarters · filed 2022-02-15 | $25.67M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $7.52M 10-Q · filed 2021-04-27 | $13.93M derived: sum of 2 quarters · filed 2022-02-15 | $19.42M derived: sum of 3 quarters · filed 2022-02-15 | $26.45M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $11.89M derived: sum of 2 quarters · filed 2022-02-15 | $18.93M derived: sum of 3 quarters · filed 2022-02-15 | $24.39M 10-K · filed 2022-02-15 |
| 2019-09-30 | $5.49M 10-Q · filed 2020-10-27 | $12.53M derived: sum of 2 quarters · filed 2020-10-27 | $17.98M 10-Q · filed 2020-10-27 | $24.54M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $7.04M 10-Q · filed 2020-07-28 | $12.50M 10-Q · filed 2020-07-28 | $19.06M derived: sum of 3 quarters · filed 2021-02-16 | $25.21M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $5.46M 10-Q · filed 2020-04-29 | $12.02M derived: sum of 2 quarters · filed 2021-02-16 | $18.17M derived: sum of 3 quarters · filed 2021-02-16 | $23.12M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $6.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $12.71M derived: sum of 2 quarters · filed 2021-02-16 | $17.66M derived: sum of 3 quarters · filed 2021-02-16 | $20.77M 10-K · filed 2021-02-16 |
| 2018-09-30 | $6.15M 10-Q · filed 2019-10-29 | $11.10M derived: sum of 2 quarters · filed 2019-10-29 | $14.21M 10-Q · filed 2019-10-29 | $16.59M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $4.95M 10-Q · filed 2019-07-30 | $8.05M 10-Q · filed 2019-07-30 | $10.44M derived: sum of 3 quarters · filed 2020-02-25 | $15.75M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $3.11M 10-Q · filed 2019-04-30 | $5.49M derived: sum of 2 quarters · filed 2020-02-25 | $10.80M derived: sum of 3 quarters · filed 2020-02-25 | $15.60M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $7.70M derived: sum of 2 quarters · filed 2020-02-25 | $12.49M derived: sum of 3 quarters · filed 2020-02-25 | $17.82M 10-K · filed 2020-02-25 |
| 2017-09-30 | $5.32M 10-Q · filed 2018-10-30 | $10.11M derived: sum of 2 quarters · filed 2018-10-30 | $15.44M 10-Q · filed 2018-10-30 | $15.69M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $4.79M 10-Q · filed 2018-07-31 | $10.12M 10-Q · filed 2018-07-31 | $10.37M derived: sum of 3 quarters · filed 2019-02-26 | $12.92M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $5.33M 10-Q · filed 2018-05-01 | $5.58M derived: sum of 2 quarters · filed 2019-02-26 | $8.13M derived: sum of 3 quarters · filed 2019-02-26 | $11.35M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $247.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $2.79M derived: sum of 2 quarters · filed 2019-02-26 | $6.02M derived: sum of 3 quarters · filed 2019-02-26 | $8.53M 10-K · filed 2019-02-26 |
| 2016-09-30 | $2.55M 10-Q · filed 2017-10-31 | $5.77M derived: sum of 2 quarters · filed 2017-10-31 | $8.29M 10-Q · filed 2017-10-31 | $9.22M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $3.23M 10-Q · filed 2017-08-01 | $5.74M 10-Q · filed 2017-08-01 | $6.67M derived: sum of 3 quarters · filed 2018-02-27 | $7.31M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $2.51M 10-Q · filed 2017-05-02 | $3.45M derived: sum of 2 quarters · filed 2018-02-27 | $4.09M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2015-12-31 | $935.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.58M derived: sum of 2 quarters · filed 2018-02-27 | $843.00K 10-K · filed 2018-02-27 | |
| 2015-09-30 | $641.00K 10-Q · filed 2016-11-03 | -$92.00K 10-Q · filed 2016-11-03 | ||
| 2014-12-31 | -$6.70M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |